Impact of intrapartum antibiotic prophylaxis on the oral and fecal bacteriomes of children in the first week of life.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 15 02 2024
accepted: 30 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 6 8 2024
Statut: epublish

Résumé

Intrapartum antibiotic prophylaxis (IAP) is commonly used during C-section delivery and in Group B Streptococcus-positive women before vaginal delivery. Here, we primarily aimed to investigate the effect of IAP on the neonatal oral and fecal bacteriomes in the first week of life. In this preliminary study, maternal and neonatal oral swabs and neonatal fecal (meconium and transitional stool) swabs were selected from a pool of samples from healthy mother-neonate pairs participating in the pilot phase of CELSPAC: TNG during their hospital stay. The DNA was extracted and bacteriome profiles were determined by 16S rRNA amplicon sequencing (Illumina). In the final dataset, 33 mother-neonate pairs were exposed to antibiotics during C-section or vaginal delivery (cases; +IAP) and the vaginal delivery without IAP (controls, -IAP) took place in 33 mother-neonate pairs. Differences in alpha diversity (Shannon index, p=0.01) and bacterial composition (PERMANOVA, p<0.05) between the +IAP and -IAP groups were detected only in neonatal oral samples collected ≤48 h after birth. No significant differences between meconium bacteriomes of the +IAP and -IAP groups were observed (p>0.05). However, the IAP was associated with decreased alpha diversity (number of amplicon sequence variants, p<0.001), decreased relative abundances of the genera Bacteroides and Bifidobacterium, and increased relative abundances of genera Enterococcus and Rothia (q<0.01 for all of them) in transitional stool samples. The findings of this study suggest that exposure to IAP may significantly influence the early development of the neonatal oral and gut microbiomes. IAP affected the neonatal oral bacteriome in the first two days after birth as well as the neonatal fecal bacteriome in transitional stool samples. In addition, it highlights the necessity for further investigation into the potential long-term health impacts on children.

Identifiants

pubmed: 39107353
doi: 10.1038/s41598-024-68953-z
pii: 10.1038/s41598-024-68953-z
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18163

Subventions

Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : 65269705
Organisme : Ministerstvo Školství, Mládeže a Tělovýchovy
ID : LM2023069
Organisme : Horizon 2020 Framework Programme
ID : 857560
Organisme : HORIZON EUROPE European Research Council
ID : No 101136566

Informations de copyright

© 2024. The Author(s).

Références

Shao, Y. et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 574, 117–21 (2019).
pubmed: 31534227 pmcid: 6894937 doi: 10.1038/s41586-019-1560-1
Mueller, N. T., Bakacs, E., Combellick, J., Grigoryan, Z. & Dominguez-Bello, M. G. The infant microbiome development: Mom matters. Trends Mol. Med. 21, 109–17 (2015).
pubmed: 25578246 doi: 10.1016/j.molmed.2014.12.002
Grech, A. et al. Maternal exposures and the infant gut microbiome: A systematic review with meta-analysis. Gut Microbes 13, 1–30 (2021).
pubmed: 33978558 doi: 10.1080/19490976.2021.1897210
Bäckhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690–703 (2015).
pubmed: 25974306 doi: 10.1016/j.chom.2015.04.004
Rutayisire, E., Huang, K., Liu, Y. & Tao, F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: A systematic review. BMC Gastroenterol. 16, 86 (2016).
pubmed: 27475754 pmcid: 4967522 doi: 10.1186/s12876-016-0498-0
Shaterian, N., Abdi, F., Ghavidel, N. & Alidost, F. Role of cesarean section in the development of neonatal gut microbiota: A systematic review. Open Med. Wars Pol. 16, 624–39 (2021).
doi: 10.1515/med-2021-0270
Pivrncova, E., Kotaskova, I. & Thon, V. Neonatal diet and gut microbiome development after C-section during the first three months after birth: A systematic review. Front. Nutr. 9, 941549 (2022).
pubmed: 35967823 pmcid: 9364824 doi: 10.3389/fnut.2022.941549
Nardi, G. M. et al. Maternal and neonatal oral microbiome developmental patterns and correlated factors: A systematic review—does the apple fall close to the tree?. Int. J. Environ. Res. Public Health 18, 5569 (2021).
pubmed: 34071058 pmcid: 8197112 doi: 10.3390/ijerph18115569
Sandall, J. et al. Short-term and long-term effects of caesarean section on the health of women and children. Lancet (London, England) 392, 1349–57 (2018).
pubmed: 30322585 doi: 10.1016/S0140-6736(18)31930-5
Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U. S. A. 107, 11971–5 (2010).
pubmed: 20566857 pmcid: 2900693 doi: 10.1073/pnas.1002601107
Bokulich, N. A. et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aad7121 (2016).
doi: 10.1126/scitranslmed.aad7121 pubmed: 27306664 pmcid: 5308924
Nogacka, A. et al. Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates. Microbiome 5, 93 (2017).
pubmed: 28789705 pmcid: 5549288 doi: 10.1186/s40168-017-0313-3
Money, D., Allen, V. M., Infectious Diseases Committee. The prevention of early-onset neonatal group B streptococcal disease. J. Obstet. Gynaecol. Can. JOGC 35, 939–948 (2013).
pubmed: 24165063 doi: 10.1016/S1701-2163(15)30818-5
Betran, A. P., Ye, J., Moller, A.-B., Souza, J. P. & Zhang, J. Trends and projections of caesarean section rates: Global and regional estimates. BMJ Glob. Health 6, e005671 (2021).
pubmed: 34130991 pmcid: 8208001 doi: 10.1136/bmjgh-2021-005671
Seale, A. C. et al. Estimates of the burden of group b streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 65(Suppl 2), S200-19 (2017).
doi: 10.1093/cid/cix664
Trijbels-Smeulders, M. et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch. Dis. Child. Fetal Neonatal Ed. 92, F271-276 (2007).
pubmed: 17227807 pmcid: 2675425 doi: 10.1136/adc.2005.088799
Schrag, S. J. & Verani, J. R. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 31(Suppl 4), D20-26 (2013).
pubmed: 23219695 doi: 10.1016/j.vaccine.2012.11.056
Zhu, Y. & Lin, X.-Z. Updates in prevention policies of early-onset group B streptococcal infection in newborns. Pediatr. Neonatol. 62, 465–75 (2021).
pubmed: 34099416 doi: 10.1016/j.pedneo.2021.05.007
Hasperhoven, G., Al-Nasiry, S., Bekker, V., Villamor, E. & Kramer, B. Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: A systematic review and meta-analysis. BJOG Int. J. Obstet. Gynaecol. 127, 680–91 (2020).
doi: 10.1111/1471-0528.16085
Van Dyke, M. K. et al. Evaluation of universal antenatal screening for group B streptococcus. N. Engl. J. Med. 360, 2626–36 (2009).
pubmed: 19535801 doi: 10.1056/NEJMoa0806820
Stearns, J. C. et al. Intrapartum antibiotics for GBS prophylaxis alter colonization patterns in the early infant gut microbiome of low risk infants. Sci. Rep. 7, 16527 (2017).
pubmed: 29184093 pmcid: 5705725 doi: 10.1038/s41598-017-16606-9
Zimmermann, P. & Curtis, N. Effect of intrapartum antibiotics on the intestinal microbiota of infants: A systematic review. Arch. Dis. Child. Fetal Neonatal Ed. 105, 201–8 (2020).
pubmed: 31296695 doi: 10.1136/archdischild-2018-316659
Hirsch, A. G. et al. Early life antibiotic use and subsequent diagnosis of food allergy and allergic diseases. Clin. Exp. Allergy J. Br. Soc. Allergy Clin. Immunol. 47, 236–44 (2017).
doi: 10.1111/cea.12807
Kummeling, I. et al. Early life exposure to antibiotics and the subsequent development of eczema, wheeze, and allergic sensitization in the first 2 years of life: The KOALA birth cohort study. Pediatrics 119, e225-31 (2007).
pubmed: 17200248 doi: 10.1542/peds.2006-0896
Azad, M. B., Bridgman, S. L., Becker, A. B. & Kozyrskyj, A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obes. 38, 1290–8 (2014).
doi: 10.1038/ijo.2014.119
Gomez Arango, L. et al. Antibiotic treatment at delivery shapes the initial oral microbiome in neonates. Sci. Rep. 7, 43481 (2017).
pubmed: 28240736 pmcid: 5378909 doi: 10.1038/srep43481
Tapiainen, T. et al. Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants. Sci. Rep. 9, 10635 (2019).
pubmed: 31337807 pmcid: 6650395 doi: 10.1038/s41598-019-46964-5
Chen, Y. Y. et al. Impact of maternal intrapartum antibiotics, and caesarean section with and without labour on bifidobacterium and other infant gut microbiota. Microorganisms 9, 1847 (2021).
pubmed: 34576741 pmcid: 8467529 doi: 10.3390/microorganisms9091847
Azad, M. et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: A prospective cohort study. BJOG Int. J. Obstet. Gynaecol. 123, 983–93 (2016).
doi: 10.1111/1471-0528.13601
Aloisio, I. et al. Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains. Appl. Microbiol. Biotechnol. 98, 6051–60 (2014).
pubmed: 24687755
Zhou, P. et al. Perinatal antibiotic exposure affects the transmission between maternal and neonatal microbiota and is associated with early-onset sepsis. mSphere 5, e00984-19 (2020).
pubmed: 32075882 pmcid: 7031618 doi: 10.1128/mSphere.00984-19
Pavlova, T. et al. Urinary intermediates of tryptophan as indicators of the gut microbial metabolism. Anal. Chim. Acta 987, 72–80 (2017).
pubmed: 28916042 doi: 10.1016/j.aca.2017.08.022
Videnska, P. et al. Stool sampling and DNA isolation kits affect DNA quality and bacterial composition following 16S rRNA gene sequencing using MiSeq Illumina platform. Sci. Rep. 9, 13837 (2019).
pubmed: 31554833 pmcid: 6761292 doi: 10.1038/s41598-019-49520-3
Douglas, C. A. et al. DNA extraction approaches substantially influence the assessment of the human breast milk microbiome. Sci. Rep. 10, 123 (2020).
pubmed: 31924794 pmcid: 6954186 doi: 10.1038/s41598-019-55568-y
Claassen, S. et al. A comparison of the efficiency of five different commercial DNA extraction kits for extraction of DNA from faecal samples. J. Microbiol. Methods 94, 103–10 (2013).
pubmed: 23684993 pmcid: 5809576 doi: 10.1016/j.mimet.2013.05.008
Kotásková, I. et al. Actinotignum schaalii: Relation to concomitants and connection to patients’ conditions in polymicrobial biofilms of urinary tract catheters and urines. Microorganisms 9, 669 (2021).
pubmed: 33807120 pmcid: 8004716 doi: 10.3390/microorganisms9030669
Tourlousse, D. M. et al. Synthetic spike-in standards for high-throughput 16S rRNA gene amplicon sequencing. Nucleic Acids Res. 45, e23 (2017).
pubmed: 27980100
Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. 108, 4516–22 (2011).
pubmed: 20534432 doi: 10.1073/pnas.1000080107
Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–3 (2016).
pubmed: 27214047 pmcid: 4927377 doi: 10.1038/nmeth.3869
Aronesty, E. Comparison of sequencing utility programs. Open Bioinform. J. 7, 1–8 (2013).
doi: 10.2174/1875036201307010001
Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335–6 (2010).
pubmed: 20383131 pmcid: 3156573 doi: 10.1038/nmeth.f.303
Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, D590-6 (2013).
pubmed: 23193283 doi: 10.1093/nar/gks1219
Baldassarre, M. E. et al. Duration of meconium passage in preterm and term infants. Arch. Dis. Child. Fetal Neonatal Ed. 95, F74-75 (2010).
pubmed: 20019200 doi: 10.1136/adc.2009.159442
Davis, N. M., Proctor, D. M., Holmes, S. P., Relman, D. A. & Callahan, B. J. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome 6, 226 (2018).
pubmed: 30558668 pmcid: 6298009 doi: 10.1186/s40168-018-0605-2
Pincus, R. & Aitchison, J. The Statistical Analysis of Compositional Data. Biom J. 30, 794–794 (Chapman and Hall, London, New York, 1988).
R: The R Project for Statistical Computing. https://www.r-project.org/ (2023).
Van den Boogaart, K. & Tolosana-Delgado, R. Compositional data analysis with `R’ and the package ‘compositions’. Geol. Soc. 264(1), 119–127 (2006).
Oksanen, J, et al. Vegan: Community Ecology Package. http://cran.r-project.org (2022).
Kassambara, A. & Mundt, F. Factoextra: Extract and visualize the results of multivariate data analyses. https://CRAN.R-project.org/package=factoextra (2020).
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2009).
Murray, M. & Blume, J. FDRestimation: Estimate, Plot, and Summarize False Discovery Rates. https://doi.org/10.12688/f1000research.52999.2 (2022).
Conway, J. & Gehlenborg N. UpSetR: A More Scalable Alternative to Venn and Euler Diagrams for Visualizing Intersecting Sets. https://doi.org/10.1093/bioinformatics/btx364 (2019).
Guo, H. et al. The dynamic communities of oral microbiome in neonates. Front. Microbiol. 13, 1052525 (2022).
pubmed: 36560953 pmcid: 9764626 doi: 10.3389/fmicb.2022.1052525
Ferretti, P. et al. Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome. Cell Host Microbe 24, 133-145.e5 (2018).
pubmed: 30001516 pmcid: 6716579 doi: 10.1016/j.chom.2018.06.005
Dzidic, M. et al. Oral microbiome development during childhood: An ecological succession influenced by postnatal factors and associated with tooth decay. ISME J. 12, 2292–306 (2018).
pubmed: 29899505 pmcid: 6092374 doi: 10.1038/s41396-018-0204-z
Belizário, J. E. & Napolitano, M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front. Microbiol. 6, 1050 (2015).
pubmed: 26500616 pmcid: 4594012 doi: 10.3389/fmicb.2015.01050
Xiao, J., Fiscella, K. A. & Gill, S. R. Oral microbiome: Possible harbinger for children’s health. Int. J. Oral Sci. 12, 1–13 (2020).
doi: 10.1038/s41368-020-0082-x
Sampaio-Maia, B. & Monteiro-Silva, F. Acquisition and maturation of oral microbiome throughout childhood: An update. Dent. Res. J. 11, 291–301 (2014).
Chu, D. M. et al. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med. 23, 314–26 (2017).
pubmed: 28112736 pmcid: 5345907 doi: 10.1038/nm.4272
Verma, D., Garg, P. K. & Dubey, A. K. Insights into the human oral microbiome. Arch. Microbiol. 200, 525–40 (2018).
pubmed: 29572583 doi: 10.1007/s00203-018-1505-3
Lif Holgerson, P., Harnevik, L., Hernell, O., Tanner, A. C. R. & Johansson, I. Mode of birth delivery affects oral microbiota in infants. J. Dent. Res. 90, 1183–8 (2011).
pubmed: 21828355 pmcid: 3173012 doi: 10.1177/0022034511418973
Dzidic, M. et al. Oral microbiota maturation during the first 7 years of life in relation to allergy development. Allergy 73, 2000–11 (2018).
pubmed: 29602225 doi: 10.1111/all.13449
Boix-Amorós, A., Collado, M. C. & Mira, A. Relationship between milk microbiota, bacterial load, macronutrients, and human cells during lactation. Front. Microbiol. 7, 492 (2016).
pubmed: 27148183 pmcid: 4837678 doi: 10.3389/fmicb.2016.00492
Miyoshi, T. et al. Gemella haemolysans inhibits the growth of the periodontal pathogen Porphyromonas gingivalis. Sci. Rep. 11, 11742 (2021).
pubmed: 34083694 pmcid: 8175725 doi: 10.1038/s41598-021-91267-3
Peng, X. et al. Oral microbiota in human systematic diseases. Int. J. Oral Sci. 14, 1–11 (2022).
doi: 10.1038/s41368-022-00163-7
Li, H. et al. The impacts of delivery mode on infant’s oral microflora. Sci. Rep. 8, 11938 (2018).
pubmed: 30093722 pmcid: 6085361 doi: 10.1038/s41598-018-30397-7
Hurley, E. et al. The microbiota of the mother at birth and its influence on the emerging infant oral microbiota from birth to 1 year of age: A cohort study. J. Oral Microbiol. 11, 1599652 (2019).
pubmed: 32128038 pmcid: 7034431 doi: 10.1080/20002297.2019.1599652
Kennedy, B. et al. Oral microbiota development in early childhood. Sci. Rep. 9, 19025 (2019).
pubmed: 31836727 pmcid: 6911045 doi: 10.1038/s41598-019-54702-0
Dierikx, T. H. et al. The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review. J. Infect. 81, 190–204 (2020).
pubmed: 32389786 doi: 10.1016/j.jinf.2020.05.002
Jauréguy, F. et al. Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants. J. Clin. Microbiol. 42, 5184–8 (2004).
pubmed: 15528713 pmcid: 525278 doi: 10.1128/JCM.42.11.5184-5188.2004
Arboleya, S., Saturio, S. & Gueimonde, M. Impact of intrapartum antibiotics on the developing microbiota: A review. Microbiome Res. Rep. 1, 22 (2022).
pubmed: 38046905 pmcid: 10688785 doi: 10.20517/mrr.2022.04
Imoto, N. et al. Administration of β-lactam antibiotics and delivery method correlate with intestinal abundances of Bifidobacteria and Bacteroides in early infancy, in Japan. Sci. Rep. 11, 6231 (2021).
pubmed: 33737648 pmcid: 7973812 doi: 10.1038/s41598-021-85670-z
Saturio, S. et al. Effect of intrapartum antibiotics prophylaxis on the bifidobacterial establishment within the neonatal gut. Microorganisms 9, 1867 (2021).
pubmed: 34576761 pmcid: 8471514 doi: 10.3390/microorganisms9091867
Corvaglia, L. et al. Influence of intrapartum antibiotic prophylaxis for group B streptococcus on gut microbiota in the first month of life. J. Pediatr. Gastroenterol. Nutr. 62, 304 (2016).
pubmed: 26237371 doi: 10.1097/MPG.0000000000000928
Dierikx, T. et al. Influence of timing of maternal antibiotic administration during caesarean section on infant microbial colonisation: A randomised controlled trial. Gut 71, 1803–11 (2022).
pubmed: 34803023 doi: 10.1136/gutjnl-2021-324767
Mazzola, G. et al. Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B streptococcal disease. PLoS ONE 11, e0157527 (2016).
pubmed: 27332552 pmcid: 4917232 doi: 10.1371/journal.pone.0157527

Auteurs

Eliska Pivrncova (E)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Lucie Buresova (L)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Iva Kotaskova (I)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
BioVendor MDx, Karasek 1, Brno, Czech Republic.

Petra Videnska (P)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Lenka Andryskova (L)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Pavel Piler (P)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Petr Janku (P)

Department of Gynecology and Obstetrics, University Hospital Brno, Jihlavska 20, Brno, Czech Republic.
Department of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, Czech Republic.

Ivo Borek (I)

Department of Neonatology, University Hospital Brno, Jihlavska 20, Brno, Czech Republic.
Department of Neonatology, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, Czech Republic.

Jan Bohm (J)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Jana Klanova (J)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Eva Budinska (E)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Petra Borilova Linhartova (P)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic. petra.linhartova@recetox.muni.cz.
Clinic of Maxillofacial Surgery, University Hospital Brno, Jihlavska 20, Brno, Czech Republic. petra.linhartova@recetox.muni.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH